NASDAQ:CRIS - Curis, Inc.
$2.39
 $0.09
+3.91%
11:45AM EDT
2019-07-22
Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of Class I and II HDAC, as well as Class I PI3K enzymes. CA-170 is an oral small molecule drug candidate that is designed to selectively target programmed death ligand-1 (PDL1) and V-domain Ig suppressor of T-cell activation (VISTA) immune checkpoint proteins, both of which independently function as negative regulators of immune activation. CA-4948 is an oral small molecule drug candidate that is designed to inhibit the Interleukin-1 receptor-associated kinase 4 (IRAK4) kinase, which is a transducer of toll-like receptor or certain interleukin receptor signaling pathways. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CRIS     avg for
industry  
  avg for
sector  
42 stocks weight:  12. 89   217. 37   399. 45  
42 stocks rank:  3. 52 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  1. 00   2. 10   2. 04  

quick ratio:  9. 63   5. 49   1. 88  
current ratio:  9. 81   5. 87   2. 36  

target price low:  2. 86   83. 44   114. 90  
target price avg:  2. 86   106. 20   137. 90  
target price high:  2. 86   132. 30   158. 97  
1-yr high:  2. 83   111. 86   142. 57  
last close:  2. 30   86. 79   125. 44  
50-day avg:  1. 74   86. 68   122. 63  
200-day avg:  1. 49   89. 22   121. 38  
1-yr low:  0. 62   69. 78   100. 51  
volume:  612. 52 K 2. 62 M 3. 43 M
50-day avg volume:  186. 03 K 3. 20 M 4. 16 M
200-day avg volume:  395. 28 K 2. 99 M 4. 75 M

1-day return:  1. 77 % -1. 30 % -0. 99 %
this week return:  2. 22 % 0. 45 % -0. 20 %
12-wk return:  29. 21 % 0. 94 % 4. 84 %
52-wk return:  41. 32 % -1. 30 % 10. 55 %

enterprise value (EV):  36. 32 M 45. 10 B 122. 38 B
market cap:  76. 25 M 38. 96 B 108. 40 B
EBITDA:  -24. 82 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 46   5. 38   11. 93  
enterprise/revenue (EV/R):  3. 73   57. 92   10. 21  
total revenue:  9. 73 M 9. 91 B 39. 98 B
total debt:  878. 00 K 10. 90 B 17. 48 B
net income (common):  -31. 71 M 2. 07 B 4. 05 B

shares outstanding:  33. 15 M 538. 09 M 1. 24 B
shares:  24. 49 M 548. 00 M 1. 22 B
shares short:  453. 34 K 10. 98 M 11. 87 M
shares short prior month:  459. 59 K 9. 32 M 12. 05 M
short ratio:  4. 46   5. 60   3. 34  
short % of float:  1. 65 % 6. 48 % 2. 64 %
total cash/share:  1. 29   10. 98   9. 19  
total cash:  42. 80 M 5. 93 B 6. 10 B
free cash flow:  -16. 91 M 2. 92 B 4. 55 B
operating cash flow:  -30. 70 M 3. 80 B 5. 78 B

book value:  -0. 41   13. 35   27. 45  
price/book:  -5. 56   4. 60   8. 78  
gross profits:  -14. 55 M 7. 44 B 36. 13 B
operating margins:  -256. 84 % -308. 40 % -28. 55 %
EBITDA margins:  -255. 21 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  -113. 46 % 35. 80 % 55. 40 %

1-yr max volatility:  32. 02 % --- ---
1-yr mean volatility:  4. 29 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 96   2. 10   4. 23  
P/E:  -2. 40   1. 90   32. 10  
PE/G:  0. 08   0. 70   -0. 54  
growth:  -28. 40 % 265. 63 % 79. 11 %
earnings high:  -0. 00   0. 89   1. 68  
earnings avg:  -0. 00   0. 70   1. 57  
earnings low:  -0. 00   0. 46   1. 46  
revenue high:  2. 40 M 2. 57 B 11. 07 B
revenue avg:  2. 40 M 2. 51 B 10. 91 B
revenue low:  2. 40 M 2. 45 B 10. 73 B
return on assets:  -26. 73 % -2. 34 % 5. 28 %
return on equity:  -8594. 04 % -90. 08 % 133. 53 %
revenue growth:  -28. 40 % 265. 25 % 73. 68 %
revenue/share:  0. 29   12. 72   60. 04  

beta (1yr vs S&P500):  1. 47   1. 27   0. 91  
sharpe (1yr):  0. 76   0. 16   0. 77  

held % insiders:  17. 28 % 6. 06 % 3. 29 %
held % institutions:  24. 15 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CRIS
.    101.304 =       101.304 :: --> INITIAL WEIGHT <--
.    - 0.957 =       100.347 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.028 =       203.533 :: P/E factor
.    x 1.854 =       377.363 :: PE/G factor
.    x 1.589 =       599.588 :: beta factor
.    x 0.914 =       547.818 :: sharpe factor
.    x 2.329 =      1275.719 :: current ratio factor
.    x 1.056 =       1347.63 :: quick ratio factor
.    x 1.106 =      1491.075 :: short ratio factor
.    x 1.064 =      1587.195 :: EV/R factor
.     x 4.96 =      7872.844 :: debt-to-revenue factor
.                               --> PERFORMANCE <--
.    x 2.121 =     16696.673 :: sector+industry 1-year gains factor
.    x 1.009 =      16854.09 :: industry 12-weeks return factor
.    x 1.308 =     22043.272 :: industry 2-weeks return factor
.    x 2.285 =     50369.291 :: 5-day avg > 200-day avg
.    x 2.709 =    136472.217 :: 5-day avg > 50-day avg
.    x 1.167 =    159314.603 :: 50-day avg > 200-day avg
.     x 0.98 =    156195.423 :: "drift" penalty 1 days ago
.     x 0.96 =    149897.934 :: "drift" penalty 2 days ago
.    x 0.925 =    138702.641 :: "drift" penalty 3 days ago
.     x 0.97 =    134578.428 :: "drift" penalty 4 days ago
.    / 2.167 =     62108.428 :: overall "drift" factor
.    x 0.595 =     36945.414 :: largest single-day jump factor
.    x 0.067 =      2482.891 :: low price factor
.    x 0.196 =        486.51 :: notable returns + performance factor
.     x 3.23 =      1571.512 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.365 =       572.907 :: forward P/E factor
.    x 1.185 =        678.73 :: industry recommendation factor
.    x 2.463 =      1671.996 :: company recommendation factor
.    x 1.003 =       1676.62 :: factor historical industry gain for week 29
.    x 9.853 =     16520.078 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        11.337 :: reduced for readability
.    + 1.553 =         12.89 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      12.89 :: FINAL WEIGHT for NASDAQ:CRIS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org